Two COVID-19 vaccine doses ‘highly effective’ in immune-mediated inflammatory disease

A two-dose vaccine course is “highly effective” against COVID-19 infection and severe outcomes in patients with rheumatoid arthritis, ankylosing spondylitis, psoriasis and inflammatory bowel disease, according to data.“We felt it was a priority to evaluate the effectiveness of COVID-19 vaccines in patients with immune-mediated inflammatory diseases, as these patients were excluded from the initial vaccine clinical trials,” Jessica Widdifield, PhD, of the Sunnybrook Research Institute, in Toronto, told Healio. “Studies have also shown that these patients are at anRead More